Literature DB >> 29102947

Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease.

Vania Cuna1, Viola Menghi1, Giorgia Comai1, Maria Cappuccilli1, Giuseppe Cianciolo1, Concettina Raimondi1, Francesco Grammatico1, Gabriele Donati1, Olga Baraldi1, Irene Capelli1, Gaetano LA Manna2.   

Abstract

BACKGROUND/AIM: Clinical and subclinical hypothyroidism is more common in patients with end-stage renal disease (ESRD) than in the general population. Patients with ESRD with hypothyroidism are more susceptible to cardiovascular disease, with an increased risk of mortality than those with normal thyroid function. Moreover, these patients have higher incidence of benign and malignant nodules. PATIENTS AND METHODS: This was a retrospective study on 2,147 patients with ESRD on the renal transplant waiting list between 2000 and 2015 aimed at identifying the presence of hypothyroidism and associated variables.
RESULTS: Hypothyroidism was detected in 437/2,147 (20.3%) patients, 289 of them having the subclinical form. Cardiovascular disease and older age were significantly associated with hypothyroidism, and autosomal polycystic kidney disease was correlated to goiter (p<0.001).
CONCLUSION: Thyroid abnormalities, particularly hypothyroidism with nodules, should be investigated in patients with ESRD on a waiting list for renal transplant to control cardiovascular complications and cancer risk. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cancer; cardiovascular disease; end-stage renal disease; hypothyroidism; thyroid abnormalities; thyroid nodules; waiting list for renal transplant

Mesh:

Year:  2017        PMID: 29102947      PMCID: PMC5756653          DOI: 10.21873/invivo.11191

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  31 in total

1.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

2.  Improved cardiovascular risk factors in pediatric renal transplant recipients on steroid avoidance immunosuppression: A study of the Midwest Pediatric Nephrology Consortium.

Authors:  Donald J Weaver; David Selewski; Halima Janjua; Franca Iorember
Journal:  Pediatr Transplant       Date:  2015-11-20

Review 3.  Vitamin D in thyroid disorders.

Authors:  P Kmieć; K Sworczak
Journal:  Exp Clin Endocrinol Diabetes       Date:  2015-07-14       Impact factor: 2.949

4.  The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.

Authors:  N Inoue; M Watanabe; N Ishido; Y Katsumata; T Kagawa; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

5.  Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients.

Authors:  Ronney S Shantouf; Matthew J Budoff; Naser Ahmadi; Arshia Ghaffari; Ferdinand Flores; Ambarish Gopal; Nazanin Noori; Jennie Jing; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2010-04-09       Impact factor: 3.754

6.  Extrarenal manifestations of autosomal dominant polycystic kidney disease.

Authors:  S K Ha; C H Park; J S Kna; S Y Lee; J I Lee; S J Kim; J K Seo; H Y Lee; D S Han
Journal:  Yonsei Med J       Date:  1997-04       Impact factor: 2.759

Review 7.  Thyroid hormone and the kidney.

Authors:  A I Katz; D S Emmanouel; M D Lindheimer
Journal:  Nephron       Date:  1975       Impact factor: 2.847

Review 8.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 9.  Age- and race-based serum thyrotropin reference limits.

Authors:  Martin I Surks; Laura Boucai
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

Review 10.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

View more
  5 in total

1.  Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Laura Cotoi; Florin Borcan; Ioan Sporea; Daniela Amzar; Oana Schiller; Adalbert Schiller; Cristina A Dehelean; Gheorghe Nicusor Pop; Andreea Borlea; Dana Stoian
Journal:  Diagnostics (Basel)       Date:  2020-04-23

2.  Prevalence of Hypothyroidism among Dialysis Patients in Palestine: A Cross-Sectional Study.

Authors:  Zaher A Nazzal; Emad N Khazneh; Razan A Rabi; Ahlam A Hammoudeh; Ahmed F Ghanem; Mohammed A Zaidan
Journal:  Int J Nephrol       Date:  2020-05-13

3.  Benign nodules of the thyroid gland and 25-hydroxy-vitamin D levels in euthyroid patients.

Authors:  Hacı Bolat; Aliriza Erdoğan
Journal:  Ann Saudi Med       Date:  2022-04-07       Impact factor: 1.526

4.  Incidence of thyroid nodules in early stage autosomal polycystic kidney disease.

Authors:  Ewa Zalewska; Sonia Kaniuka-Jakubowska; Piotr Wiśniewski; Magdalena Jankowska; Krzysztof Sworczak; Alicja Dębska-Ślizień
Journal:  BMC Nephrol       Date:  2022-03-03       Impact factor: 2.388

Review 5.  Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature.

Authors:  Emanuela Cataldo; Valeria Columbano; Louise Nielsen; Lurlynis Gendrot; Bianca Covella; Giorgina Barbara Piccoli
Journal:  BMC Nephrol       Date:  2018-07-02       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.